Match Document Document Title
7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists  
The present invention relates to a series of substituted bis aryl and heteroaryl compounds of formula (I): Wherein X, Y, Z, A, B, D, Ar, R 1 and R 2 are as defined herein. The compounds of...
7625902 Imidazolidinone derivatives  
The invention is concerned with novel imidazolidinone derivatives of formula (I): wherein R 1 to R 11 and X are as defined in the description and in the claims, as well as physiologically...
7626040 Substituted imidazole compounds as KSP inhibitors  
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with...
7612060 Triazoles and methods of use  
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically...
7612201 Pyrazole compounds  
Compounds of formula (IA) or (IB) or a salt, N-oxide, hydrate or solvate thereof are inhibitors of HSP90, and are of value in the treatment of diseases responsive to HSP90 inhibition such as...
7605162 Phenylpiperazine  
The invention relates to a novel group of phenylpiperazines having interesting pharmacological properties such as a high affinity for the dopamine D 2 receptor and/or the serotonin reuptake site,...
7598250 Cyclic amine BACE-1 inhibitors having a heterocyclic substituent  
Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is X is —O—, —C(R 14 ) 2 — or —N(R)—; Z is...
7595322 Heterocyclic sulfonamides as modulators of cardiac sarcomeres  
Certain substituted sulfonamide derivatives of Formula I selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart...
7595330 Benzimidazole thiophene compounds  
The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
7582635 Therapeutic agents useful for treating pain  
A compound of formula: wherein Ar 1 , A, R 3 , x, and m are as disclosed herein and Ar 2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt...
7572921 Substituted benzylimidazoles useful for the treatment of inflammatory diseases  
The invention comprises a class of derivatives of substituted benzylimidazoles of the formula (I) and methods for making the same. These compounds are useful for the treatment of inflammatory...
7557108 (Indol-4-yl) or (indol-5-yl)-piperazinylmethanones  
The present invention relates to compounds of formula I wherein one of R 1 and R 2 is hydrogen and the other one is and wherein A and R 1 to R 4 are as defined in the description and...
7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands  
The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine D 3 receptors. In another aspect, the invention relates to a method for treating...
7547698 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)  
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise, for example, administering to a mammal in need thereof a...
7514436 Pyridazine derivatives and their use as therapeutic agents  
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula...
7479502 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors  
The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these...
7439360 Vanilloid receptor ligands and their use in treatments  
Therapeutic benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular...
7420057 Stable polymorph of flibanserin  
The invention relates to the polymorph A of flibanserin, to a technical process for the preparation thereof, as well as to the use thereof for preparing medicaments.
7414058 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders  
There is disclosed a method for the treatment of Extra Pyramidal syndrome (EPS) comprising the administration of an adenosine A2a receptor antagonist, alone or in combination with other agents...
7396834 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders  
Compounds of general formula: wherein R 1 and R 2 are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared....
7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride  
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-y l)-piperazine, crystalline modification of the...
7351822 Serine protease inhibitors  
Compounds of formula (I) in which R 2 , X, Y, Cy, L and Lp(D) n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment...
7351828 Benzimidazoles that are useful in treating sexual dysfunction  
The present invention relates to the use of compounds of formula (I) for the treatment of sexual dysfunction and to compositions containing compounds of formula (I) for the treatment of sexual...
7335660 Isochroman compounds for treatment of CNS disorders  
This invention relates to compounds of formula (I) where R 1 to R 12 , —W—V—, —X—Y—, p and n have the values defined in claim 1 , their preparation and use as pharmaceuticals for...
7329749 Piperazinylcarbonylquinolines and -isoquinolines  
Compound of the formula (I) in which R 1 , R 2 and alk are as defined in Claim 1, are potent 5-HT 2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression,...
7291642 Bradykinin-B1 antagonists, process for their preparation and their use as medicaments  
The present invention provides bradykinin-B1 antagonists of the formula in which A, Ar, G, Q, R 1 and R 4 are as defined in claim 1, their enantiomers, their diastereomers, their mixtures and...
7241787 Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments  
The invention relates to substituted N-cyclohexylheterocycles and to the physiologically tolerated salts and physiologically functional derivatives thereof, to processes for their preparation and...
7223764 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound  
The present invention is directed to a 2,4-bis(trifluoroethoxy)pyridine compound represented by formula (1): (wherein X 1 represents a fluorine atom or a hydrogen atom) or a salt thereof, and...
7214679 Piperidine/piperazine-type inhibitors of p38 kinase  
Compounds of the formula: wherein the substituents are as defined herein are useful for treating conditions mediated by p38 kinase.
7214796 Process for production of 1-[2-(benzimidazol-2-yl-thio)ethyl]piperazine or salts thereof  
This invention relates to a method for producing 1-[2-(benzimidazol-2-ylthio)ethyl]piperazine (5) or its salt by the following reaction scheme: This invention enables efficient production of...
RE39608 Substituted benzimidazoles and their use as PARP inhibitors  
Compounds of the formula Ia or IB where A is a saturated or monounsaturated heterocyclic, 4 - to 8-membered ring which contains one or two nitrogen atoms, and their tautomeric forms,...
7202233 Alprazolam inclusion complexes and pharmaceutical compositions thereof  
A pharmaceutical composition an inclusion complex and methods for treating patients and preparing said complex disclosed for transmucosal delivery comprising an inclusion complex of (a) alprazolam...
7189726 Benzofuran derivatives as inhibitors of p38-α kinase  
The invention is directed to methods to inhibit p38-α kinase using compounds which contain an aromatic residue coupled to an benzofuran moiety through a piperidine.
7186724 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands  
The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D 3 receptors. In another aspect, the invention relates to a method for treating...
7169775 Amino methyl imidazoles as C5a receptor modulators  
Amino methyl imidazoles of Formula I are provided: wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are defined herein. Such compounds are ligands of C5a receptors. Preferred compounds of...
7160912 Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them  
The present invention relates to novel oxazolidinone compounds of formula (I), their stereoisomers, their salts and pharmaceutical compositions containing them. The present invention also...
7160886 Acylated piperazine derivatives as melanocortin-4 receptor agonists  
Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are...
7144883 Bicyclic sulfonamide compounds  
The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful...
7138420 Substituted benzimidazole compounds  
Disclosed are substituted benzimidazole compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 and X a are defined herein. The compounds of the invention inhibit Itk kinase and are therefore...
7135473 Cyclic diamine compound with condensed-ring groups  
A cyclic diamine compound of formula (1): wherein R 1 and R 2 are individually a hydrogen atom or a methoxy group, provided R 1 is a methoxy group when R 2 is a hydrogen atom, or a hydrogen...
7132421 CIS-imidazoles  
The present invention provides compounds according to formula I and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction...
7125877 Benzimidazole derivatives  
This invention provides compounds which are represented by a general formula [I] [in which X stands for hydrogen or halogen; B stands for halogen, cyano or optionally fluorine-substituted lower...
7119086 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use  
The invention relates to compounds of formula: and also to the salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, with affinity for and selectivity towards...
7115644 Heterocyclic compounds  
Disclosed are benzimidazolone compounds of formulas (I) & (II): wherein R 1 , R 2 , R 3 , R 4 , R 5 , X, L, m, n and t are defined herein. The compounds inhibit production of cytokines...
7091219 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors  
Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease...
7067513 Phenylpiperazines  
The invention relates to a novel group of phenylpiperazines having interesting pharmacological properties such as a high affinity for the dopamine D 2 receptor and/or the serotonin reuptake site,...
7056918 Benzimidazole anti-inflammatory compounds  
The present invention relates to novel triazolo-pyridines of the formula I wherein Het is an optionally substituted 5-membered heterocycle containing one to two heteroatoms selected from...
7030113 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders  
The present invention discloses compounds of formula I wherein Ar, Z, m, n, p, R 1 and R 8 are herein defined, said compounds being novel antagonists for melanin-concentrating hormone (MCH),...
7030150 Benzimidazole compounds and antiviral uses thereof  
The present invention relates to novel benzimidazole compounds that have useful antiviral activity. More specifically, the invention encompasses benzimidazole compounds that inhibit membrane fusion...
7026314 Therapeutic chromone compounds  
Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating,...